Chronic hepatitis B affects millions of people globally, and, in severe cases, can lead to liver cancer and liver failure. Clinical trials offer participants the opportunity to try potential treatments, as well as help move the science forward. For people living with hepatitis B, current treatments may reduce long term complications. A new clinical trial is researching the safety and effectiveness of an investigational treatment option. If you have hepatitis B, you may be eligible for this trial.
If you would like to speak to someone regarding this trial first check to see if you are eligible above. If it seems that you are eligible to take part, you will be contact by phone so we can ask you additional eligiblity questions, and you will be able to ask any additional questions you may have about this clinical trial.